These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32031639)

  • 41. In vitro selection of resistance in Escherichia coli and Klebsiella spp. at in vivo fluoroquinolone concentrations.
    Drago L; Nicola L; Mattina R; De Vecchi E
    BMC Microbiol; 2010 Apr; 10():119. PubMed ID: 20409341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131.
    Ben Zakour NL; Alsheikh-Hussain AS; Ashcroft MM; Khanh Nhu NT; Roberts LW; Stanton-Cook M; Schembri MA; Beatson SA
    mBio; 2016 Apr; 7(2):e00347-16. PubMed ID: 27118589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.
    Martín-Gutiérrez G; Rodríguez-Beltrán J; Rodríguez-Martínez JM; Costas C; Aznar J; Pascual Á; Blázquez J
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4252-8. PubMed ID: 27139482
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genomic trajectories to fluoroquinolone resistance in Francisella tularensis subsp. holarctica live vaccine strain.
    Sutera V; Hennebique A; Lopez F; Fernandez N; Schneider D; Maurin M
    Int J Antimicrob Agents; 2020 Dec; 56(6):106153. PubMed ID: 32911069
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of the mechanisms of fluoroquinolone resistance in urinary tract pathogens.
    Chenia HY; Pillay B; Pillay D
    J Antimicrob Chemother; 2006 Dec; 58(6):1274-8. PubMed ID: 17040923
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of Inhibitor-Resistant TEM β-Lactamases and Mechanisms of Fluoroquinolone Resistance in Escherichia coli Isolates.
    Ríos E; López MC; Rodríguez-Avial I; Pena I; Picazo JJ
    Microb Drug Resist; 2015 Oct; 21(5):512-5. PubMed ID: 25945693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Multidrug-resistant bacteria compensate for the epistasis between resistances.
    Moura de Sousa J; Balbontín R; Durão P; Gordo I
    PLoS Biol; 2017 Apr; 15(4):e2001741. PubMed ID: 28419091
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A national study confirms that Escherichia coli from Australian commercial layer hens remain susceptible to critically important antimicrobials.
    Abraham R; Allison HS; Lee T; Pavic A; Chia R; Hewson K; Lee ZZ; Hampson DJ; Jordan D; Abraham S
    PLoS One; 2023; 18(7):e0281848. PubMed ID: 37418382
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanisms of fluoroquinolone resistance in Escherichia coli isolates from food-producing animals.
    Karczmarczyk M; Martins M; Quinn T; Leonard N; Fanning S
    Appl Environ Microbiol; 2011 Oct; 77(20):7113-20. PubMed ID: 21856834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mutation in the Two-Component System Regulator YycH Leads to Daptomycin Tolerance in Methicillin-Resistant Staphylococcus aureus upon Evolution with a Population Bottleneck.
    Sulaiman JE; Wu L; Lam H
    Microbiol Spectr; 2022 Aug; 10(4):e0168722. PubMed ID: 35913149
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phenotypic and genotypic quinolone resistance in Escherichia coli underlining GyrA83/87 mutations as a target to detect ciprofloxacin resistance.
    Muggeo A; Cambau E; Amara M; Micaëlo M; Pangon B; Bajolet O; Benmansour H; de Champs C; Guillard T
    J Antimicrob Chemother; 2020 Sep; 75(9):2466-2470. PubMed ID: 32443149
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tigecycline Nonsusceptibility Occurs Exclusively in Fluoroquinolone-Resistant Escherichia coli Clinical Isolates, Including the Major Multidrug-Resistant Lineages O25b:H4-ST131-H30R and O1-ST648.
    Sato T; Suzuki Y; Shiraishi T; Honda H; Shinagawa M; Yamamoto S; Ogasawara N; Takahashi H; Takahashi S; Tamura Y; Yokota SI
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27855067
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics of Romanian fluoroquinolone-resistant human clinical Escherichia coli isolates.
    Usein CR; Tatu-Chiţoiu D; Nica M; Ciontea SA; Palade AM; Condei M; Damian M
    Roum Arch Microbiol Immunol; 2008; 67(1-2):23-9. PubMed ID: 19284163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Molecular characterization of fluoroquinolone-resistant Escherichia coli from broiler breeder farms.
    Seo KW; Lee YJ
    Poult Sci; 2021 Aug; 100(8):101250. PubMed ID: 34182220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations.
    Szili P; Draskovits G; Révész T; Bogár F; Balogh D; Martinek T; Daruka L; Spohn R; Vásárhelyi BM; Czikkely M; Kintses B; Grézal G; Ferenc G; Pál C; Nyerges Á
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31235632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bottleneck size and selection level reproducibly impact evolution of antibiotic resistance.
    Mahrt N; Tietze A; Künzel S; Franzenburg S; Barbosa C; Jansen G; Schulenburg H
    Nat Ecol Evol; 2021 Sep; 5(9):1233-1242. PubMed ID: 34312522
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The cost of antibiotic resistance depends on evolutionary history in Escherichia coli.
    Angst DC; Hall AR
    BMC Evol Biol; 2013 Aug; 13():163. PubMed ID: 23914906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Quantifying the Determinants of Evolutionary Dynamics Leading to Drug Resistance.
    Chevereau G; Dravecká M; Batur T; Guvenek A; Ayhan DH; Toprak E; Bollenbach T
    PLoS Biol; 2015; 13(11):e1002299. PubMed ID: 26581035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Occurrence of fluoroquinolones and fluoroquinolone-resistance genes in the aquatic environment.
    Adachi F; Yamamoto A; Takakura K; Kawahara R
    Sci Total Environ; 2013 Feb; 444():508-14. PubMed ID: 23291652
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Isolation of Escherichia coli strains with AcrAB-TolC efflux pump-associated intermediate interpretation or resistance to fluoroquinolone, chloramphenicol and aminopenicillin from dogs admitted to a university veterinary hospital.
    Sato T; Yokota S; Ichihashi R; Miyauchi T; Okubo T; Usui M; Fujii N; Tamura Y
    J Vet Med Sci; 2014 Jul; 76(7):937-45. PubMed ID: 24646457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.